Roy Lindsay Henry

Title: Roy Lindsay Henry: Innovator in Pharmaceutical Compositions

Introduction

Roy Lindsay Henry is a notable inventor based in Horsham, GB. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on staurosporine compositions. His expertise and dedication to research have led to the development of a unique pharmaceutical formulation.

Latest Patents

Roy Lindsay Henry holds 1 patent related to pharmaceutical compositions containing staurosporine. This patent describes an orally administrable pharmaceutical composition that comprises a solution or dispersion of a staurosporine active ingredient in a solid saturated polyalkylene glycol glyceride. The formulation can be administered in capsules or as a dispersion in an aqueous medium, showcasing its versatility and potential for effective treatment.

Career Highlights

Throughout his career, Roy has been associated with Novartis Corporation, a leading global healthcare company. His work at Novartis has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in pharmaceuticals. His dedication to innovation has positioned him as a key figure in the development of new therapeutic solutions.

Collaborations

Roy Lindsay Henry has worked alongside Graham Paul Matthews, further enhancing the collaborative spirit within the pharmaceutical research community. Their combined efforts have contributed to advancements in drug formulations and therapeutic applications.

Conclusion

Roy Lindsay Henry's contributions to pharmaceutical innovations, particularly in staurosporine compositions, highlight his role as a significant inventor in the industry. His work continues to influence the development of effective pharmaceutical solutions.